A Nomogram Prediction Model and Scoring System for Resistance in Acute Myeloid Leukemia Patients Treated with Venetoclax Combined with Hypomethylating Agents
Current Oncology · 13.06.2026 · 33 (6) · 357
DOI: 10.3390/curroncol33060357 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, online erschienen am 13.06.2026. Verfasst von Qingqing Fan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China. Hauptthemen laut MEDLINE: Nomograms, Bridged Bicyclo Compounds, Heterocyclic, Leukemia, Myeloid, Acute, Sulfonamides. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jiangsu Provincial Hospital Association.
Abstract (Originalsprache)
To investigate the predictive factors for resistance to VEN combined with HMAs in the treatment of AML, construct a drug resistance prediction model, and visualize the model. A retrospective analysis was conducted on 74 AML patients. Multivariate logistic regression was used to identify independent predictors of primary resistance, based on which a nomogram model and a risk scoring system for drug resistance were constructed. The results showed that KIT (p = 0.012), TP53 (p = 0.010), and FAB-M5 (p = 0.059) were significantly associated with primary resistance to VEN. A nomogram prediction model incorporating FAB-M5, KIT, and TP53 was established. Based on the nomogram model, a drug resistance prediction scoring tool comprising three variables was developed, categorizing patients into high-risk (6–10 points), intermediate-risk (3–5 points), and low-risk (0–2 points) groups. Significant differences in NR rates were observed among the three risk groups (p < 0.001). KIT, TP53, and FAB-M5 are independent factors influencing VEN resistance. The constructed nomogram prediction model and scoring system may provide valuable references for predicting primary resistance to VEN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.
- Department of Hematology, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.
- Research Division of Clinical Pharmacology, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.
- School of Pharmacy, Nanjing Medical University, Nanjing 211166, China.
ORCID-Profile: Yongqing Wang
Förderung
- Jiangsu Provincial Hospital Association
Zitieren
APA
Fan, Q., Guo, Y., Hui, X., Zhang, Y., Li, J., Liang, J., & Wang, Y. (2026). A Nomogram Prediction Model and Scoring System for Resistance in Acute Myeloid Leukemia Patients Treated with Venetoclax Combined with Hypomethylating Agents. Current Oncology, 33(6), 357. https://doi.org/10.3390/curroncol33060357
Vancouver
Fan Q, Guo Y, Hui X, Zhang Y, Li J, Liang J, et al. A Nomogram Prediction Model and Scoring System for Resistance in Acute Myeloid Leukemia Patients Treated with Venetoclax Combined with Hypomethylating Agents. Current Oncology. 2026;33(6):357. doi:10.3390/curroncol33060357
BibTeX
@article{Fan2026,
author = {Fan, Qingqing and Guo, Yujiao and Hui, Xiang and Zhang, Yu and Li, Jianrui and Liang, Jinhua and Wang, Yongqing},
title = {A Nomogram Prediction Model and Scoring System for Resistance in Acute Myeloid Leukemia Patients Treated with Venetoclax Combined with Hypomethylating Agents},
journal = {Current Oncology},
year = {2026},
volume = {33},
number = {6},
pages = {357},
doi = {10.3390/curroncol33060357}
}
EUVIMED